Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-06-26
1990-12-25
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3142
Patent
active
049803646
ABSTRACT:
Disclosed is the use of (+/-)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline as a nasal decongestant which, when administered orally, does not produce adverse central nervous system stimulant effects as experienced with other decongestants and anorexiants.
REFERENCES:
patent: 3161650 (1964-12-01), Poos
patent: 4256755 (1981-03-01), Smith, Jr.
Chem. Abst., 83:91037v, (1975), Engelhardt et al.
Fay Zohreh A.
Friedman Stanley J.
LandOfFree
Method of decongesting the nose without adverse stimulant effect does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of decongesting the nose without adverse stimulant effect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of decongesting the nose without adverse stimulant effect will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1163011